melbourne meeting, page-9

K18 there's one other company in this antibiotics space I've been keeping my eye on.

Trius Theraputics. Entire pipe is antibiotics. Doesn't have anything in the market yet and $200M MC.

http://www.triusrx.com/trius-therapeutics-pipeline.php

Anyhoo, they have a Gyrase candidate in preclinical as well, which is slightly different to ours in that it's gram negative and IV only. Ours is positive and IV and oral.

The US govt is funding their Gyrase program to the tune of $30M, which is why I keep on asking DL why can't we get some more loving from Uncle Sam.